PMID- 37762140 OWN - NLM STAT- MEDLINE DCOM- 20230930 LR - 20231003 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 24 IP - 18 DP - 2023 Sep 8 TI - Acute Glycemic Control in Prediabetes Individuals Favorably Alters Serum NLRP3 Inflammasome and Related Interleukins. LID - 10.3390/ijms241813837 [doi] LID - 13837 AB - Hyperglycemia associated with prediabetes (PD) alters NLRP3 inflammasome activity and related interleukins, yet no study has evaluated the expression of the NLRP3 inflammasome complex and related interleukins in individuals with a PD condition that did or did not develop type 2 diabetes mellitus (T2DM). This study investigated the effect of 6 months of lifestyle modification on the expression of the NLRP3 inflammasome and related interleukins (1alpha, 1beta, 18, 33 and 37) in the sera of individuals with a PD condition that did or did not develop T2DM. This interventional study included 67 Saudi adults (mean age = 41.9 +/- 8.0 years, mean BMI = 33.2 +/- 5.5 kg/m(2)). Overnight-fasting serum samples were collected at baseline and at the 6-month follow-up. Serum levels of NLRP3, capsase-1 and related ILs were analyzed at both visits using commercially available immunoassay kits. Results showed that IL-1alpha increased in the PD group that developed T2DM (p = 0.046), IL-33 decreased in the PD group that reverted to normal (p < 0.001) and NLRP3 decreased in the PD group that remained PD (p = 0.01). Results also showed a positive over-time correlation between NLRP3 and both IL-1alpha and IL-33 (p < 0.001 and p = 0.028, respectively). In conclusion, glycemic control favorably altered NLRP3 inflammasome complex activity, and lifestyle modification in PD individuals is crucial in reversing harmful metabolic and inflammatory phenotypes. FAU - Alfadul, Hend AU - Alfadul H AUID- ORCID: 0009-0007-8086-937X AD - Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia. FAU - Sabico, Shaun AU - Sabico S AUID- ORCID: 0000-0002-5248-2350 AD - Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia. FAU - Alnaami, Abdullah M AU - Alnaami AM AD - Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia. FAU - Amer, Osama E AU - Amer OE AUID- ORCID: 0000-0002-8657-0682 AD - Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia. FAU - Hussain, Syed D AU - Hussain SD AD - Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia. FAU - Wani, Kaiser AU - Wani K AUID- ORCID: 0000-0001-9568-6516 AD - Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia. FAU - Clerici, Mario AU - Clerici M AUID- ORCID: 0000-0001-5920-6191 AD - Department of Medical-Surgery Physiopathology and Transplantation, University of Milan, 20122 Milan, Italy. FAU - Al-Daghri, Nasser M AU - Al-Daghri NM AUID- ORCID: 0000-0001-5472-1725 AD - Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia. LA - eng GR - IFKSUDR_H174/Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia/ PT - Journal Article DEP - 20230908 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (Inflammasomes) RN - 0 (Interleukin-33) RN - 0 (Interleukins) RN - 0 (NLR Family, Pyrin Domain-Containing 3 Protein) RN - 0 (NLRP3 protein, human) SB - IM MH - Adult MH - Humans MH - Middle Aged MH - *Diabetes Mellitus, Type 2 MH - Glycemic Control MH - Inflammasomes MH - Interleukin-33 MH - Interleukins MH - NLR Family, Pyrin Domain-Containing 3 Protein MH - *Prediabetic State PMC - PMC10530894 OTO - NOTNLM OT - NLRP3 OT - chronic inflammation OT - inflammasomes OT - inflammatory disease OT - interleukins OT - prediabetes OT - type 2 diabetes mellitus COIS- The authors declare no conflict of interest. EDAT- 2023/09/28 06:43 MHDA- 2023/09/29 06:44 PMCR- 2023/09/08 CRDT- 2023/09/28 01:17 PHST- 2023/08/08 00:00 [received] PHST- 2023/09/03 00:00 [revised] PHST- 2023/09/07 00:00 [accepted] PHST- 2023/09/29 06:44 [medline] PHST- 2023/09/28 06:43 [pubmed] PHST- 2023/09/28 01:17 [entrez] PHST- 2023/09/08 00:00 [pmc-release] AID - ijms241813837 [pii] AID - ijms-24-13837 [pii] AID - 10.3390/ijms241813837 [doi] PST - epublish SO - Int J Mol Sci. 2023 Sep 8;24(18):13837. doi: 10.3390/ijms241813837.